Table 3 Distribution of cariogenic pathogens in diabetics and non-diabetics study participants
Pathogen | T1DM Uncontrolled (n = 22) | T1DM Controlled (n = 18) | Healthy (n = 23) | Total (n = 63) | Chi-square | Statistical Difference (P value) |
|---|---|---|---|---|---|---|
Mutans Streptococci saliva | 22 (100%) | 15 (83.3%) | 15 (65.2%) | 52 (82.5%) | 14.902 | 0.001* |
Mutans Streptococci Plaque | 20 (90.9%) | 13 (72.2%) | 16 (69.6%) | 49 (77.8%) | 4.310 | 0.12 |
Lactobacilli saliva | 18 (81.8%) | 13 (72.2%) | 16 (69.6%) | 47 (74.6%) | 1.581 | 0.45 |
Lactobacilli Plaque | 16 (72.7%) | 7 (38.9%) | 13 (56.5%) | 36 (57.1%) | 4.745 | 0.09 |
Candida albicans Saliva | 15 (68.2%) | 6 (33.3%) | 16 (69.6%) | 37 (58.7%) | 7.82 | 0.02* |
Candida albicans Plaque | 8 (36.4%) | 4 (22.2%) | 9 (39.1%) | 21 (33.3%) | 1.804 | 0.41 |
Other Candida Spp. Saliva | 14 (63.6%) | 7 (38.9%) | 8 (34.8%) | 29 (46%) | 4.286 | 0.12 |
Candida dubliniensis Saliva | 7 (31.8%) | 4 (22.2%) | 1 (4.3%) | 12 (19%) | ---------- | ----------- |
Candida parapsilosis Saliva | 5 (22.7%) | 3 (16.7%) | 4 (17.4%) | 12 (19%) | ---------- | ----------- |
Candida glabrata Saliva | 3 (13.6%) | 1 (5.6%) | 1 (4.3%) | 5 (7.9%) | ---------- | ----------- |
Candida tropicalis Saliva | 5 (22.7%) | 1 (5.6%) | 1 (4.3%) | 7 (11.1%) | ---------- | ----------- |
Candida krusei Saliva | 1 (4.5%) | 0 | 2 (8.7%) | 3 (4.8%) | ---------- | ----------- |
Other Candida Spp. plaque | 7 (31.8%) | 4 (22.2%) | 5 (21.7%) | 16 (25.4%) | 0.737 | 0.69 |
Candida dubliniensis Plaque | 6 (27.3%) | 1 (5.6%) | 3 (13%) | 10 (15.9%) | ---------- | ----------- |
Candida parapsilosis Plaque | 0 | 1 (5.6%) | 1 (4.3%) | 2 (3.2%) | ---------- | ----------- |
Candida glabrata Plaque | 1 (4.5%) | 1 (5.6%) | 1 (4.3%) | 3 (4.8%) | ---------- | ----------- |
Candida tropicalis Plaque | 1 (4.5%) | 1 (5.6%) | 0 | 2 (3.2%) | ---------- | ----------- |
Candida krusei Plaque | 1 (4.5%) | 0 | 0 | 1 (1.6%) | ---------- | ----------- |